Rossari Biotech Limited
NSE:ROSSARI.NS
817.8 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 302.11 | 698.32 | 374.77 | 152.08 | 292.11 | 57.42 | 6.25 | 21.35 |
| Short Term Investments
| 375.83 | 819.52 | 269.49 | 731.49 | 1,157.3 | 6.6 | 72.96 | 0.74 |
| Cash and Short Term Investments
| 677.94 | 1,517.84 | 644.26 | 883.57 | 1,449.41 | 64.02 | 79.21 | 22.09 |
| Net Receivables
| 4,258.33 | 3,539.54 | 3,066.02 | 1,467.85 | 1,229.68 | 984.07 | 673.05 | 540.4 |
| Inventory
| 2,823.26 | 1,884.78 | 1,899.32 | 953.54 | 581.7 | 548.99 | 346.14 | 262.49 |
| Other Current Assets
| 676.22 | 269.42 | 483.33 | 242.23 | 2.45 | 0.5 | 0.97 | 18.8 |
| Total Current Assets
| 8,435.75 | 7,211.58 | 6,092.93 | 3,547.19 | 3,263.24 | 1,597.58 | 1,099.37 | 843.78 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 3,619.03 | 3,266.83 | 3,479.88 | 1,681.89 | 1,105.21 | 779.51 | 532.9 | 447.49 |
| Goodwill
| 1,187.11 | 1,187.11 | 898.58 | 26.24 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 1,441.51 | 1,542.96 | 1,706.38 | 107.6 | 47.66 | 59.7 | 0.4 | 0.35 |
| Goodwill and Intangible Assets
| 2,628.62 | 2,730.07 | 2,604.96 | 133.84 | 47.66 | 59.7 | 0.4 | 0.35 |
| Long Term Investments
| 286.98 | 251.79 | 245.47 | 191.62 | 43.46 | 1.47 | -69.88 | 1.2 |
| Tax Assets
| 48.1 | 31.99 | 13.53 | 3.07 | 0.51 | 0.51 | 0.23 | 0.23 |
| Other Non-Current Assets
| 703.03 | 183.39 | 130.45 | 55.86 | 255.07 | 59.68 | 86.48 | 15.89 |
| Total Non-Current Assets
| 7,285.76 | 6,464.07 | 6,474.29 | 2,066.28 | 1,451.91 | 900.87 | 550.13 | 465.16 |
| Total Assets
| 15,721.51 | 13,675.65 | 12,567.22 | 5,613.47 | 4,715.15 | 2,498.45 | 1,649.5 | 1,308.94 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 2,190.96 | 1,851.86 | 1,861.51 | 1,311.13 | 970.04 | 1,059.82 | 439.57 | 350.19 |
| Short Term Debt
| 745.62 | 389.95 | 84.27 | -53.92 | 329.69 | 38.56 | 196.61 | 231.44 |
| Tax Payables
| 101.01 | 84.63 | 116.47 | 21.07 | 60.03 | 16.22 | 18.55 | 0.15 |
| Deferred Revenue
| 101.01 | 1,163.26 | 903.49 | 53.92 | -329.69 | -38.56 | 18.55 | 6.19 |
| Other Current Liabilities
| 1,209.78 | 63.56 | 97.37 | 190.73 | 517.06 | 158.15 | 78.13 | 58.03 |
| Total Current Liabilities
| 4,247.37 | 3,468.63 | 2,946.64 | 1,501.86 | 1,487.1 | 1,217.97 | 732.86 | 645.85 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 333.24 | 349.33 | 0 | 0 | 339.6 | 6.73 | 12.87 | 24.26 |
| Deferred Revenue Non-Current
| 109.06 | 468.16 | 0 | 0 | 355.86 | 24.24 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 514.72 | 587.2 | 689.49 | 12.88 | 5.4 | 18.12 | 20.52 | 8.35 |
| Other Non-Current Liabilities
| 39.84 | -349.33 | 879.45 | 11.01 | -339.6 | -6.73 | 12.45 | 10.63 |
| Total Non-Current Liabilities
| 996.86 | 1,055.36 | 1,568.94 | 23.89 | 361.26 | 42.36 | 45.84 | 43.24 |
| Total Liabilities
| 5,244.23 | 4,523.99 | 4,515.58 | 1,525.75 | 1,848.36 | 1,260.33 | 778.7 | 689.09 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 9,116.63 | 0 | 4,066.57 | 2,861.92 | 0 | 0 | 0 |
| Common Stock
| 110.49 | 110.31 | 110.11 | 103.86 | 101.51 | 44 | 44 | 44 |
| Retained Earnings
| 5,645.16 | 4,365.76 | 3,317.71 | 2,387.24 | 1,609.12 | 1,038.12 | 670.8 | 419.85 |
| Accumulated Other Comprehensive Income/Loss
| 10,366.79 | 35.03 | 32.86 | 21.15 | 4.87 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| -5,645.16 | -4,476.07 | 4,590.96 | -2,491.1 | -1,710.63 | 156 | 156 | 156 |
| Total Shareholders Equity
| 10,477.28 | 9,151.66 | 8,051.64 | 4,087.72 | 2,866.79 | 1,238.12 | 870.8 | 619.85 |
| Total Equity
| 10,477.28 | 9,151.66 | 8,051.64 | 4,087.72 | 2,866.79 | 1,238.12 | 870.8 | 619.85 |
| Total Liabilities & Shareholders Equity
| 15,721.51 | 13,675.65 | 12,567.22 | 5,613.47 | 4,715.15 | 2,498.45 | 1,649.5 | 1,308.94 |